Krishna Undela, MPharm., PhD

NIPER-Guwahati, India

Poster(s):

• (SLB-049) Assessment Of Arsenic and Heavy Metal Contamination in Gallbladder Cancer: Carcinogenic Risk and Implications For DALY, Quality of Life, and Treatment Survival
  Monday, August 25, 2025

  11:45 AM - 12:45 PM ET

• (A-111) Efficacy and Safety of Pharmacological Interventions for Pulmonary Arterial Hypertension (PAH): A Systematic Review and Network Meta-Analysis (NMA) of Randomized Controlled Trials (RCTs)
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET

• (A-116) Efficacy and Safety of PI3K/Akt/mTOR Inhibitors Combined with Taxane Therapy for Treatment of Breast Cancer: A Systematic Review and Meta-Analysis
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET

• (B-185) Evaluation of Productivity Losses Due to Premature Mortality from Head and Neck Cancer in Northeast India: a population-based cost analysis
  Monday, August 25, 2025

  11:30 AM - 1:00 PM ET

• (A-256) Identifying Potential Drug Triggers for Bullous Pemphigoid: A Disproportionality Analysis of the FDA Adverse Event Reporting System and Review of Case Reports
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET

• (A-284) Nicotine Replacement Therapy in Pregnancy: A Systematic Review, Meta-Analysis, and Network Meta-Analysis of Maternal-Neonatal Outcomes and Smoking Cessation
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET

• (B-246) Safety of Immune Checkpoint Inhibitors: A Systematic Review of Disproportionality Analysis Studies
  Monday, August 25, 2025

  11:30 AM - 1:00 PM ET

• (A-226) Target Fishing and Drug Repurposing for Esophageal Adenocarcinoma: An Integrated Bioinformatic and Pharmacovigilance Approach
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET